Loading…
STIM
Neuronetics, Inc.
NASDAQ· Healthcare· Medical Devices· CUSIP 64131A105
$2.94-0.68%Price as of Aug 29, 18:31 UTC · updated once a day, after the close
Key metrics
- Market cap
- $224.02M
- P/E
- —
- Forward P/E
- —
- P/B
- 12.6x
- Dividend yield
- —
- Payout
- —
- EPS
- -$0.43
- ROE
- -116.10%
- Profit margin
- -19.62%
- Revenue growth
- +9.10%
- Beta
- 1.12
- 52-week high
- $3.71
- 52-week low
- $0.80
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -47.3% over 5Y.
today you would have $417.68▼ -58.2%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 8 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $1.38 | $1.61 | $2.90 | $6.87 | $4.46 | $11.11 | $4.49 | $19.35 | |
| P/S | 1.8x | 0.6x | 1.4x | 1.2x | 3.0x | 2.1x | 5.7x | 1.3x | 6.6x |
| P/B | 3.6x | 4.3x | 3.8x | 2.5x | 3.4x |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| AMWLAmerican Well Corp | $13.21 | — | 1.0x | — | -29.12% | $224.69M |
| SLGLSol-Gel Technologies Ltd. | $68.81 | — | 4.7x | — | -40.85% | $225.28M |
| ALECAlector, Inc. | $2.02 | — | — | — | -385.11% | $225.55M |
| CRDLCardiol Therapeutics Inc. | $1.94 |
About the company
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
- 658
- Malvern, United States
Company description provided by Yahoo Finance.